ARCHIVES

Advisors Reaffirm Survival As Standard For full FDA Approval Of Cancer Drugs

This article is from The Cancer Letter archive.

Vol. 25 No. 24 | June 16, 1999

Download PDF Visit The Full Archive

Related Articles

ODAC Advises Approval Of Tamoxifen For Male Breast Cancer Treatment

November 27, 1992

In Brief: Allegra To Head NCI/Navy Branch; Sausville Promoted; Gladstein To Leave NCI For Dallas

October 25, 1991

Donald Coffey Is President-Elect Of NCCR; Coalition Elects Five New Board.

January 28, 2000

FDA Approves Gleevec In 73 Days, A Speed Record.

May 18, 2001

Conferess Ok $10.9 Bil. NIH Bidget, OAM to Get $3.5 Million

October 15, 1993

New NCI Directory

May 19, 1989